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Brief Definitive Report 
POLYMORPHONUCLEAR NEUTROPHILS  EXPRESS THE 
COMMON ACUTE LYMPHOBLAST IC  LEUKEMIA  ANT IGEN 
BY JEFFREY COSSMAN, LEONARD M. NECKERS, WARREN J. LEONARD, AND 
WARNER C. GREENE 
From the Hematopathology Section, Laboratory of Pathology, and the Metabolism Branch, National Cancer 
Institute, National Institutes of Health, Bethesda, Maryland 20205 
The antigen associated with most cases of non-T, non-B acute lymphoblast ic  
leukemia, as first described by Greaves and referred to as the common acute 
lymphoblast ic  leukemia ntigen (CALLA),  is a 95,000-100,000-mol wt surface mem- 
brane glycoprotein identif ied by both heteroantisera and monoclonal antibodies, J5, 
V IL -A  1, and BA-3 (1-5). Because of the occurrence of CALLA on the cells from most 
cases of non-T, non-B acute lymphoblast ic leukemia (common ALL),  it is a useful 
marker for the diagnosis of this disorder. In addit ion, J5 ant ibody has been adminis- 
tered as passive serotherapy in common ALL (6). Recently, this antigen has been 
detected on a variety of other cell types including some normal bone marrow cells, as 
many as 25% of cases of T cell acute lymphoblast ic leukemia (T-ALL),  Burkitt's 
lymphoma,  foll icular lymphoma,  normal  renal tubular  and glomerular epithel ium, 
fetal small intestine, and breast myoepithel ium (7, 8). Dur ing the course of investi- 
gations on the expression of CALLA in a variety of human hematopoiet ic mal ignan- 
cies, we observed reactivity of monoclonal ant i -CALLA antibodies with normal 
polymorphonuclear  neutrophils (PMN). This reactivity appears to be specific and not 
mediated by Fc receptors. Since the presence of CALLA positive cells can be 
considered indicative of involvement by lymphoma or leukemia, the expression of 
CALLA by PMN could produce falsely positive results when CALLA is examined for 
in bone marrow aspirates, peripheral  blood or other body fluids. 
Mater ia l s  and  Methods  
Cells. PMN were isolated from the peripheral blood of 13 healthy normal adult volunteers. 
The granulocyte- and erythrocyte-rich fraction was separated by gradient centrifugation with 
Ficoll-Hypaque (Accurate Chemical & Scientific Corp., Westbury, NY) (600 g, 30 min) then 
mixed 1:1 with Plasma-Gel (HTI Corporation, Buffalo, NY) for 30 min at 37°C to allow the 
erythrocytes tosettle out. The granulocyte-rich supernatant was washed three times in medium 
RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) and 
resuspended at 3 × 10*/ml. Purity of the preparations was documented morphologically on 
cytocentrifuge preparations. Cell lines studied included Raji (Burkitt's lymphoma), NALM-1 
(lymphoblast crisis of chronic myelogenous leukemia), MOLT-4 (T ALL), and HL60 (promye- 
locytic leukemia). The induction of HL60 cells to more mature myeloid cells was performed 
with dimethyl sulfoxide (DMSO) (1.25%; Microbiological Associates, Walkersville, MD) and 
12-tetradencanoyl-phorbol-13-acetate (TPA) (10 -s M; Sigma Chemical Co., St. Louis, MO) as 
previously described (9, 10). Cell suspensions were prepared from lymph nodes involved by 
follicular lymphoma (12 cases) by pressing teased-out cells through a stainless teel mesh and 
washing in RPMI 1640. 
Irnmunostaining. Indirect immunofluorescence was performed by incubating 2 × 105 ceils 
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with 100 /.tl of primary antibody or control immunoglobulin i  phosphate-buffered saline 
containing bovine serum albumin (2%) and sodium azide (0.2%) for 30 min on ice. After three 
washes, 100/tl of the fluorescein-conjugated, affinity-purified IgG fraction of goat anti-mouse 
IgG (1:40, Kirkegaard and Perry Co., Kensington, MD) was added for another 30 min on ice. 
Murine monoclonal anti-CALLA antibodies included (a) J5 in three forms (1/xg/ml): whole 
ascites and IgG-F(ab')2 (kindly provided by Dr. Jerome Ritz, Harvard University) and IgG 
fraction (Coulter Corp., Hialeah, FL); (b) BA-3 antibody (ascites, 1: 100) (4, 5) (courtesy of Dr. 
Tucker Le Bien, University of Minnesota); and (c) VIL-A1 antibody (3) (courtesy of Dr. Walter 
Knapp, University of Vienna). Other monoclonal antibodies included OKM 1, OKT6 (Ortho 
Pharmaceuticals, Raritan, N J), and Leu-1 (Becton, Dickinson & Co., Sunnyvale, CA); all were 
used at 1 /~g/ml. Additional controls included a series of nonreactive, purified murine mono- 
clonal (hybridoma) IgG proteins that were substituted for primary antibody and included one 
each of the IgG classes IgG1, IgG2a, IgG2b, and IgG3 (all at 30/xg/ml) (provided by Dr. Kenneth 
Schroer, National Institutes of Health). Nonreactive ascites from the IgGl-producing murine 
myeloma P3 × 63 (Bethesda Research Laboratories, Rockville, MD), was also used as a 
negative control. In some instances heat-inactivated (56°C, 30 minutes) normal human serum 
(1:4) or a human IgG1 myeloma protein (30/~g/ml, provided by Dr. Gerald Crabtree, National 
Institutes of Health) were added to PMN (37°C, 30 min) before immunostaining. Cells were 
subsequently washed in ice-cold buffer and stained as described above. 
Fluorescence Detection. Fluorescence was assayed on a fluorescence-activated cell sorter (FACS- 
II, B-D FACS Systems, Becton, Dickinson & Co), at 500 mW of laser power (argon laser), 488 
nm wavelength, 630 V photomultiplier tube sensitivity, and a fluorescence gain setting of 4 on 
a scale of 16. The data was recorded on a PDP-11/34 computer (Digital Electronic Corp., 
Marlboro, MA), 1023-channel histograms were generated and the percentage of fluorescent 
cells as well as the mean fluorescence intensity (mean channel number) were calculated. 
Fluorescence microscopy was performed on a Leitz Orthoplan equipped with epifluorescence 
at 450-490 nm excitation and 515 nm suppression filters. 
Immunoprecipitation a d Gel Electrophoresis. Cell surface membrane proteins or intact cells were 
labeled with 125I using laetoperoxidase and hydrogen peroxide (11). The cells were then 
solubilized in 10 mM TRIS buffer (pH 7.4) containing 0.14 M NaCI, 1% Triton-x-100, and 100 
/lg/ml phenylmethylsulfonyl fluoride. After centrifugation, these cellular extracts were then 
immunoprecipitated with J5 (2/~g/5-10 × 106 cells) and analyzed by sodium dodecyl sulfate- 
polyacrylamide g l electrophoresis (SDS-PAGE) as described previously (I 1). Parallel control 
immunoprecipitations were also performed with UPC10, a nonreactive murine IgG2a (Litton 
Bionetics, Bethesda, MD). 
Resu l ts  
The granulocyte fraction from all normal  individuals tested stained with J5, V IL-  
A1, and BA-3 (mean 89%, range 55-99%). All three preparat ions of J5, namely, 
ascites, intact IgG, and F(ab')2, reacted with granulocytes (Fig. 1 A, B). Greater than 
90% of cells stained with OKM1,  however, no fluorescence was observed with the 
nonreactive mouse ascites, purif ied murine IgG1, IgG2a, IgG2b, IgG3, antibodies 
OKT6 and Leu-1, or after omission of pr imary antibody. Further,  preincubat ion of 
cells with normal  human serum or human IgG1 did not affect either the percentage 
of cells stained by J5 or the intensity of fluorescence (Fig. 1 C). To determine whether 
ant i -CALLA ant ibody could distinguish between neutrophils and eosinophils, the 
leukocytes from normal  individuals and from a patient with hypereosinophi l ia were 
stained with the F(ab')2 fraction of J5 and sorted into fluorescent-positive and 
-negative fractions on the FACS. The cells were collected, cytocentrifuged, stained 
with Wright 's  stain, and differential counts were performed. The positive fractions 
were greatly enriched for PMN (95 and 100% for normals and 86% for the hypereo- 
sinophi l ia patient),  whereas the negative fractions were predominant ly  eosinophils, 
lymphocytes,  and monocytes. The fluorescence intensity of neutrophils tained with 
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FIG. 1. (A) J5 staining of granulocytes a  compared with control (murine IgG2a) shows 98% of 
cells stained. Linear scale. (B) Log transformation f histogram from A amplifies the positive 
staining reaction of granulocytes with J5. Log scale (two decades). (C) Granulocytes and follicular 
lymphoma had comparable fluorescence intensity when stained with J5. These granulocytes were 
pretreated with normal human serum and showed no diminution of fluorescence intensity when 
stained with J5. Preincubation with human IgG1 myeloma protein or staining with the F(ah')2 
fraction of j5 showed similar fluorescence (not shown). The small negative peak in the granulocyte 
fraction was sorted and proved to be largely eosinophils. Linear scale. (D) The Burkitt's lymphoma 
ceil line, Raji, and a common ALL cell line, NALM-1, reacted with J5 and the relative intensity of 
the fluorescence was greater than that of granulocytes. Linear scale, The control in all cases was a 
murine IgG~ monoctonal protein. All other negative controls produced similar esults (see text). 
Each curve includes I0,000 cells counted. 
j5 was comparable to that observed with follicular lymphoma cells but less than that 
found with Raji cells (mean channel 160) and NALM-1 cells (mean channel 180) 
(Fig. 1 D). The average mean fluorescence channel was 83 for PMN (10 samples) and 
102 for follicular lymphomas (12 samples). IgG-J5 also reacted with HL60; however, 
this interaction appeared to be mediated through Fc receptors ince (a) staining was 
inhibited by preincubation with human serum or human IgG1 myeloma protein, and 
(b) F(ab')2 J5 did not react with HL60. Addition of either TPA or DMSO to HL60 
cells did not result in induction of specific J5 reactivity during a 5-d course. 
The membrane determinant detected on PMN by ant i -CALLA antibodies was 
biochemically characterized by cell surface labeling, immunoprecipitat ion, a d SDS- 
PAGE gel electrophoresis. Autoradiographs of these gels demonstrated that J5 anti- 
body identified a protein on the cell surface of PMN of ~95,000-110,000 mol wt, and 
was similar in size to that found on Raji cells (95,000-100,000 mol wt) (Fig. 2). These 
proteins recognized by J5 were not present in immunoprecipitates performed with 
control UPC10 IgG2a monoclonal antibodies or on the T cell leukemia cell line, 
MOLT-4.  
Discussion 
These studies demonstrate hat the anti -CALLA monoclonal antibodies, J5, VIL- 
A1, and BA-3 consistently react with human polymorphonuclear neutrophils but not 
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FIG. 2. SDS-PAGE analysis of lzSI-surface-labeled c lls after immunoprecipitation. Molecular 
weight standards are shown in the left lane. PMN (a, b), Raji (c, d), and Molt-4 (e, f) were 
immunoprecipltated with a nonreactive murine IgG2a 0JPC10) (a,c, e) or j5 (b, d, f). From PMN, 
J5 immunopreeipitated a single band that has a molecular weight similar to that of the band 
obtained with Raji cells. These proteins were ot immunoprecipitated with Molt-4 cells or with 
UPC 10 monoclonal antibodies. 
with other leukocytes. This reactivity does not appear to be mediated by cell surface 
Fc receptors ince staining persisted after saturation of  these receptors with either 
human IgG1 myeloma protein or normal human serum. Furthermore, the F(ab')2 
fraction and the intact IgG form of J5 showed equivalent reactivity. Other routine 
IgG2a antibodies, including Leu-1, did not react with granulocytes. Preparative cell 
sorting of J5-positive and -negative fractions indicated that the J5-positive cells 
observed among granulocytes and unseparated peripheral blood leukocytes were, 
indeed, PMN. 
The antigen detected on the cell membrane of PMN was similar in size to CALLA 
present on Raji cells (95,000-110,000 tool wt for PMN and 95,000-100,000 mol wt 
for Raji) and was immunostained by three different ant i -CALLA antibodies. Thus, 
the antigen detected on PMN not only shares an epitope with CALLA,  but these 
antigens may be identical. Although blasts from the lymphoblast crisis of chronic 
myelogenous leukemia (CML) are frequently CALLA-positive (2, 4, 7), CALLA may 
not be expressed on myeloid precursor cells since; (a) the cells of the stable phase of 
CML are reported to lack CALLA (7); (b) ant i -CALLA (J5) treatment does not 
inhibit proliferation in myeloid clonal assays (12); and (c) as observed in the present 
study, the promyelocytic leukemia cell line, HL60, did not specifically stain with J5. 
Thus, CALLA appears to be acquired at a late stage of PMN differentiation. Although 
ant i -CALLA antibodies have a role in the diagnosis of lymphoma and leukemia, 
admixed PMN in patient samples could masquerade as CALLA-positive malignant 
cells. As an example, the pleural effusion from a patient with follicular lymphoma 
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Fro. 3. Dot plot display of FACS-II analysis of a pleural fluid from a patient with follicular 
lymphoma stained with J5. A cluster of large, stained cells is seen in the upper ight. This stained 
cell population was sorted and was found to consist of polymorphonuclear neutrophils. 
contained 6% J5-stained cells (Fig. 3). This result was init ial ly interpreted as indicat ing 
a low level of involvement by the neoplastic process. However, when these stained 
cells were sorted on the FA(3S, they proved to be entirely composed of PMN. 
Therefore, caution should be exercised when studying effusions, bone marrow aspi- 
rates, and especially unseparated leukocyte buffy coats as has been suggested for 
immunofluorescence analysis by flow cytometry (13). 
Summary  
Monoclonal  antibodies J5, VIL-A1, and BA-3, known to react with the common 
acute lymphoblast ic  leukemia antigen (CALLA) were found to specifically stain 
normal human polymorphonuclear  neutrophils (PMN). The antigen detected on 
PMN had a molecular weight (95,000-110,000 mol wt) close to that of CALLA 
(95,000-100,000 mol wt) and thus these surface membrane antigens are likely related, 
if not identical. The fluorescent staining intensity of PMN is comparable to that of 
CALLA-posit ive leukemic cells and the presence of PMN in patient samples could 
potential ly produce false-positive results in diagnosis. 
Received for publication 13 December 1983. 
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